Nozu, Kandai <br/><br/>
The pharmacological characteristics of molecular-based inherited salt-losing tubulopathies.  [electronic resource] 

 -  The Journal of clinical endocrinology and metabolism  Dec 2010 
 - E511-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1945-7197 
<br/><br/><label>Standard No.: </label>10.1210/jc.2010-0392  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bartter Syndrome--drug therapy<br/>Child<br/>DNA Mutational Analysis<br/>Diuretics--therapeutic use<br/>Exons--genetics<br/>Female<br/>Frameshift Mutation<br/>Furosemide--therapeutic use<br/>Gitelman Syndrome--drug therapy<br/>Humans<br/>Male<br/>Mutation<br/>Receptors, Drug--genetics<br/>Sequence Deletion--genetics<br/>Sodium-Potassium-Chloride Symporters--genetics<br/>Solute Carrier Family 12, Member 1<br/>Solute Carrier Family 12, Member 3<br/>Symporters--genetics<br/>Thiazides--therapeutic use<br/>Young Adult